Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Issues Draft Guidance For Physiologic Closed-Loop Control Devices

Executive Summary

The US agency’s draft document highlights technical considerations to enhance safety and efficacy for the development of medical devices employing physiologic closed-loop control technology. PCLC tech can benefit health care providers by lessening their workloads.

You may also be interested in...



FDA No Longer Publishing Quarterly PMA And HDE Decisions

The US FDA has stopped publishing its list of approvals and denials of premarket approval applications (PMAs) and humanitarian device exemptions (HDEs) in the Federal Register on a quarterly basis. The agency says the change will save money and resources.

Biden Pledges A Billion COVID-19 Tests, Announces Plan Requiring Private Insurers To Pay For At-Home Diagnostics

The Biden administration announced on 13 January that it’s purchasing an additional 500 million COVID-19 tests to be distributed free to any American wanting one, bringing the total to 1 billion tests procured. 

Telehealth Study Rates All 50 States On Patient Access To Virtual Care

Several US states hit hardest by COVID-19 have the most restrictive telehealth laws, according to a report from the Reason Foundation, Cicero Institute and Pioneer Institute. As telehealth becomes more integrated into the country’s health care system, states should adopt more reforms so residents can benefit from the advancing technology, the report urges. 

Topics

UsernamePublicRestriction

Register

MT144889

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel